Five Prime Therapeutics, Inc.: SC 14D9/A filed Apr 16, 2021

Form type

SC 14D9/A

Filing date

Apr 16, 2021

Accession number

0001193125-21-118574

Filer

Five Prime Therapeutics, Inc. (CIK 1175505)